We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Diverse Chronic Kidney Diseases Diagnosed with Exome Sequencing

By LabMedica International staff writers
Posted on 08 Jan 2019
Exome sequencing is emerging as a first-line diagnostic method in some clinical disciplines, but its usefulness has yet to be examined for most constitutional disorders in adults, including chronic kidney disease, which affects more than 1 in 10 persons globally.

Targeted capture and sequencing of the protein-coding regions of the genome through exome sequencing is increasingly applied as a first-line diagnostic tool in clinical medicine, particularly for the diagnosis of metabolic and neurodevelopmental disorders in children, as well as for the detection of causal mutations in cancer.

A large team of scientists led by those at Columbia University (New York, NY, USA) conducted exome sequencing and diagnostic analysis in two cohorts totaling 3,315 patients with chronic kidney disease. More...
In all, 3,037 patients (91.6%) were over 21 years of age, and 1,179 (35.6%) were of self-identified non-European ancestry.

Genomic DNA was isolated from samples obtained from patients in accordance with standard protocols, and of sequence capture was performed using either the NimbleGen SeqCap Exome EZ kit or the IDT xGen Exome Research Panel kit and analyzed with an in-house pipeline to identify diagnostic variants for patients’ renal disease. Paired-end sequencing was performed on the 2500 HiSeq platform or the Illumina NovaSeq 6000 platform, using 125bp and 150bp reads, respectively.

The scientists detected among the 307 patients diagnosed with the help of exome sequence data, the team saw 206 autosomal dominant disease cases, 42 individuals with autosomal recessive disease, 54 X-linked conditions, and five individuals with more than one molecular diagnosis. The proportion of cases diagnosed with exome sequences notched up in the cases not diagnosed previously with standard clinical testing. There, the exome sequences led to molecular diagnoses in 48 (more than 17%) of those cases. Another 18 patients had their diagnoses refined with the new genetic data, while secondary findings in non-kidney disease-related genes, including immunosuppression-related genes, informed the types of treatments provided for still more individuals with chronic kidney disease.

The authors concluded that their findings support the diagnostic utility of exome sequencing across different clinical categories of kidney disease and highlight the potential of genetic testing to accurately direct patients to relevant clinical trials and targeted therapies, encouraging similar investigations across other subspecialties. The study was published on December 13, 2018, in the journal The New England Journal of Medicine.

Related Links:
Columbia University


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
Rapid Test Reader
DIA5000
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.